利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

38 条记录 (耗时 0.045 秒)

    Thienopyridine compounds, their production and use
    2.
    发明授权
    Thienopyridine compounds, their production and use 失效
    噻吩并吡啶化合物，其生产和使用

    公开(公告)号：US06329388B2

    公开(公告)日：2001-12-11

    申请号：US09736641

    申请日：2000-12-14

    申请人： Shuichi Furuya ,  Nobuo Choh ,  Nobuhiro Suzuki ,  Takashi Imada

    发明人： Shuichi Furuya ,  Nobuo Choh ,  Nobuhiro Suzuki ,  Takashi Imada

    IPC分类号： A61K31435

    CPC分类号： C07D495/04

    摘要： The compounds of the present invention possess excellent gonadotropin-releasing hormone antagonizing activity, and is useful for preventing or treating sex hormone-dependent diseases, e.g., sex hormone-dependent cancers (e.g., prostatic cancer, uterine cancer, breast cancer, pituitary tumor), prostatic hypertrophy, hysteromyoma, endometriosis, precocious puberty, amenorrhea syndrome, multilocular ovary syndrome, pimples etc, or as a pregnancy regulator (e.g., contraceptive), infertility remedy or menstruation regulator.

    摘要翻译： 本发明的化合物具有优异的促性腺激素释放激素拮抗活性，并且可用于预防或治疗性激素依赖性疾病，例如性激素依赖性癌症（例如前列腺癌，子宫癌，乳腺癌，垂体瘤） ，前列腺肥大，子宫肌瘤，子宫内膜异位症，早熟青春期，闭经综合征，多腔卵巢综合征，丘疹等，或作为妊娠调节剂（如避孕药），不育补救或月经调节剂。

    Thienopyrimidine compounds, their production and use
    3.
    发明授权
    Thienopyrimidine compounds, their production and use 失效
    噻吩并嘧啶化合物，其生产和使用

    公开(公告)号：US06297379B1

    公开(公告)日：2001-10-02

    申请号：US09530495

    申请日：2000-04-26

    申请人： Shuichi Furuya ,  Nobuhiro Suzuki ,  Nobuo Choh ,  Yoshi Nara

    发明人： Shuichi Furuya ,  Nobuhiro Suzuki ,  Nobuo Choh ,  Yoshi Nara

    IPC分类号： C07D49504

    CPC分类号： C07D495/04

    摘要： A compound of formula (I) wherein R1 and R2 each is hydrogen, hydroxy, C1-4 alkoxy, C1-4 alkoxy-carbonyl or C1-4 alkyl which may be substituted; R3 is hydrogen, halogen, hydroxy or C1-4 alkoxy which may be substituted; or adjacent two R3 may form C1-4 alkylenedioxy; R4 is hydrogen or C1-4 alkyl; R6 is C1-4 alkyl which may be substituted or a group of the formula (A) wherein R5 is hydrogen of R4 and R5 may form heterocycle; and n is 0-5, or a salt thereof, has an excellent GnRH-antagonizing activity, and is useful for preventing or treating sex hormone-dependent diseases.

    摘要翻译： 其中R 1和R 2各自为氢，羟基，C 1-4烷氧基，C 1-4烷氧基 - 羰基或可被取代的C 1-4烷基的式（I）化合物; R3是氢，卤素，羟基或可被取代的C1-4烷氧基; 或相邻的两个R 3可以形成C 1-4亚烷基二氧基; R4是氢或C1-4烷基; R 6是可以被取代的C 1-4烷基或式（A）的基团，其中R 5是氢的R 4和R 5可以形成杂环; n为0-5或其盐具有优异的GnRH拮抗活性，可用于预防或治疗性激素依赖性疾病。

    Thienopyridine compound
    4.
    发明授权
    Thienopyridine compound 失效
    噻吩并吡啶化合物

    公开(公告)号：US06262267B1

    公开(公告)日：2001-07-17

    申请号：US09402206

    申请日：1999-09-30

    申请人： Shuichi Furuya ,  Nobuo Choh ,  Nobuhiro Suzuki ,  Takashi Imada

    发明人： Shuichi Furuya ,  Nobuo Choh ,  Nobuhiro Suzuki ,  Takashi Imada

    IPC分类号： C07D47104

    CPC分类号： C07D495/04

    摘要： The compound of the present invention possesses excellent gonadotropin-releasing hormone antagonizing activity, and is useful for preventing or treating sex hormone-dependent diseases, e,g., sex hormone-dependent cancers (e.g., prostatic cancer, uterine cancer, breast cancer, pituitary tumor), prostatic hypertrophy, hysteromyoma, endometriosis, precocious puberty, amenorrhea sydrome, multilocular ovary sydrome, pimples etc, or as a pregnancy regulator (e.g., contraceptive), infertility remedy or menstruation regulator.

    摘要翻译： 本发明的化合物具有优异的促性腺激素释放激素拮抗活性，并且可用于预防或治疗性激素依赖性疾病，例如性激素依赖性癌症（例如，前列腺癌，子宫癌，乳腺癌， 垂体肿瘤），前列腺肥大，子宫肌瘤，子宫内膜异位症，早熟青春期，闭经症状，多腔卵巢综合征，丘疹等，或作为妊娠调节者（如避孕药），不育补救或月经调节剂。

    Nitrogen-containing heterocyclic compounds, their production and use
    5.
    发明授权
    Nitrogen-containing heterocyclic compounds, their production and use 失效
    含氮杂环化合物，其生产和使用

    公开(公告)号：US06194419B1

    公开(公告)日：2001-02-27

    申请号：US09147616

    申请日：1999-02-02

    申请人： Shuichi Furuya ,  Toshihiro Imaeda ,  Satoshi Sasaki

    发明人： Shuichi Furuya ,  Toshihiro Imaeda ,  Satoshi Sasaki

    IPC分类号： A61K31519

    CPC分类号： C07D487/04 ,  A61K31/506

    摘要： A compound of the formula: wherein one of A and D is N and the other is C, or both are N; B is N or C; m is 0-3; R1, R2 and R3 each is (i) H or (ii) a group bound via C, N, O or S; R4 is a group bound via C; R5 is H or a group bound via C or O; R6 is H or a group bound via C; R7 is a homo- or hetero-cyclic group which may be substituted; or a salt thereof possesses excellent gonadotropin-releasing hormone antagonizing activity, and is useful as a prophylactic or therapeutic agent for sex hormone-dependent diseases, and so forth.

    摘要翻译： 下式的化合物：其中A和D中的一个为N，另一个为C，或两者均为N; B是N或C; m为0-3; R1，R2和R3各自为（i）H或（ii）通过C，N，O或S键合的基团; R4是通过C键合的基团; R5是H或通过C或O键合的基团; R6是H或通过C键合的基团; R7是可以被取代的同 - 或异环 - 基团; 或其盐具有优异的促性腺激素释放激素拮抗活性，并且可用作性激素依赖性疾病的预防或治疗剂等。

    Liposome Preparation
    7.
    发明申请
    Liposome Preparation 审中-公开
    脂质体制备

    公开(公告)号：US20090169610A1

    公开(公告)日：2009-07-02

    申请号：US12223517

    申请日：2007-02-02

    申请人： Noboru Yamazaki ,  Sei Yoshida ,  Masuo Yamaoka ,  Akira Hori ,  Shigeya Kakimoto ,  Shuichi Furuya

    发明人： Noboru Yamazaki ,  Sei Yoshida ,  Masuo Yamaoka ,  Akira Hori ,  Shigeya Kakimoto ,  Shuichi Furuya

    IPC分类号： A61K9/127 ,  A61K39/395

    CPC分类号： A61K9/1271 ,  A61K9/1272 ,  A61K31/282 ,  A61K31/337 ,  A61K31/513 ,  A61K31/537 ,  A61K31/573 ,  A61K31/7068 ,  A61K47/6911

    摘要： The present invention provides cancer treatment preparations of excellent targetability. The sugar chain-modified liposomes of the present invention, which contain an aromatase inhibitor, anti-androgenic agent, lyase inhibitor, GnRH agonist, GnRH antagonist, anti-angiogenic agent, tyrosine kinase inhibitor, serine-threonine kinase inhibitor, antibody having an anticancer activity, ansamitocin, capecitabine, celmoleukin, docetaxel hydrate, gemcitabine hydrochloride, oxaliplatin, prednisolone, tegafur-uracil mixtures, zinostatin stimalamer or arsenic trioxide may be used as cancer treatment preparations having an excellent targetability.

    摘要翻译： 本发明提供了具有优异目标性的癌症治疗制剂。 含有芳香酶抑制剂，抗雄激素剂，裂解酶抑制剂，GnRH激动剂，GnRH拮抗剂，抗血管生成剂，酪氨酸激酶抑制剂，丝氨酸 - 苏氨酸激酶抑制剂，抗癌剂的本发明糖链修饰脂质体 活性，安曲霉素，卡培他滨，纤维白蛋白，多西紫杉醇水合物，盐酸吉西他滨，奥沙利铂，泼尼松龙，替加氟 - 尿嘧啶混合物，维生素D抑制素或三氧化二砷可用作具有优异靶向性的癌症治疗制剂。

    Quinoline derivatives, their production and use
    9.
    发明授权
    Quinoline derivatives, their production and use 失效
    喹啉衍生物，其生产和使用

    公开(公告)号：US5807869A

    公开(公告)日：1998-09-15

    申请号：US779609

    申请日：1997-01-07

    申请人： Shuichi Furuya ,  Nobuo Choh ,  Satoshi Sasaki

    发明人： Shuichi Furuya ,  Nobuo Choh ,  Satoshi Sasaki

    IPC分类号： C07D215/56 ,  A61K31/47

    CPC分类号： C07D215/56

    摘要： The present quinoline derivatives and compositions having gonadotropin-releasing hormone antagonistic activity are useful as propylactics or therapeutic agent for the prevention or treatment of several hormone dependent diseases, for example, a sex hormone dependent cancer (e.g. prostatic cancer, uterine or cervical cancer, breast cancer, pituitary adenoma), benign prostatic hypertrophy, myoma of the uterus, endometriosis, precocious puberty, amenorrhea, premenstrual syndrome, polycystic ovary syndrome and acne vulgaris; are effective as a fertility controlling agent in both sexes (e.g. a pregnancy controlling agent and a menstrual cycle controlling agent); can be used as a male or female contraceptive, as an ovulation-inducing agent; can be used as an infertility treating agent by using a rebound effect owing to a stoppage of administration thereof; and are useful for modulating estrous cycles in animals in the field of animal husbandry, as agents for improving the quality of edible meat or promoting the growth of animals, and as agents for promoting spawning in fish.

    摘要翻译： 本发明的喹诺酮衍生物和具有促性腺激素释放激素拮抗作用的组合物可用作预防或治疗若干激素依赖性疾病，例如性激素依赖性癌症（例如前列腺癌，子宫颈癌或宫颈癌，乳腺癌）的丙型或治疗剂 癌症，垂体腺瘤），良性前列腺肥大，子宫肌瘤，子宫内膜异位症，早熟性青春期，闭经，经前期综合征，多囊卵巢综合征和寻常型痤疮; 作为两性生育调节剂（例如妊娠控制剂和月经周期控制剂）有效; 可用作男性或女性避孕药，作为排卵诱导剂; 可以通过使用由于其施用停止而产生的反弹效应而用作不育处理剂; 可用于调节畜牧业动物的发情周期，作为改善食用肉质量或促进动物生长的药剂，以及用于促进鱼类产卵的药剂。